Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more
Core Laboratories NV (CLB) - Net Assets
Latest net assets as of December 2025: $279.76 Million USD
Based on the latest financial reports, Core Laboratories NV (CLB) has net assets worth $279.76 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($596.95 Million) and total liabilities ($317.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $279.76 Million |
| % of Total Assets | 46.86% |
| Annual Growth Rate | 6.96% |
| 5-Year Change | 73.76% |
| 10-Year Change | 80.15% |
| Growth Volatility | 56.83 |
Core Laboratories NV - Net Assets Trend (1995–2025)
This chart illustrates how Core Laboratories NV's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Core Laboratories NV (1995–2025)
The table below shows the annual net assets of Core Laboratories NV from 1995 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $279.76 Million | +8.55% |
| 2024-12-31 | $257.74 Million | +12.15% |
| 2023-12-31 | $229.81 Million | +21.62% |
| 2022-12-31 | $188.95 Million | +17.36% |
| 2021-12-31 | $161.00 Million | +113.04% |
| 2020-12-31 | $75.57 Million | -58.51% |
| 2019-12-31 | $182.14 Million | +13.20% |
| 2018-12-31 | $160.90 Million | +8.18% |
| 2017-12-31 | $148.73 Million | -4.23% |
| 2016-12-31 | $155.30 Million | +755.29% |
| 2015-12-31 | $-23.70 Million | -125.21% |
| 2014-12-31 | $93.99 Million | -44.51% |
| 2013-12-31 | $169.39 Million | -9.86% |
| 2012-12-31 | $187.91 Million | +3.44% |
| 2011-12-31 | $181.66 Million | -37.86% |
| 2010-12-31 | $292.34 Million | +3.76% |
| 2009-12-31 | $281.76 Million | +75.76% |
| 2008-12-31 | $160.31 Million | +151.95% |
| 2007-12-31 | $63.63 Million | -13.17% |
| 2006-12-31 | $73.28 Million | -65.97% |
| 2005-12-31 | $215.32 Million | +12.52% |
| 2004-12-31 | $191.37 Million | -13.60% |
| 2003-12-31 | $221.48 Million | -14.32% |
| 2002-12-31 | $258.49 Million | -6.49% |
| 2001-12-31 | $276.42 Million | +8.94% |
| 2000-12-31 | $253.75 Million | +20.72% |
| 1999-12-31 | $210.20 Million | +6.11% |
| 1998-12-31 | $198.10 Million | +71.81% |
| 1997-12-31 | $115.30 Million | +142.23% |
| 1996-12-31 | $47.60 Million | +27.96% |
| 1995-12-31 | $37.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Core Laboratories NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $279.76 Million | 100.00% |
| Total Equity | $279.76 Million | 100.00% |
Core Laboratories NV Competitors by Market Cap
The table below lists competitors of Core Laboratories NV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Maanshan Iron & Steel Company Limited
PINK:MAANF
|
$751.18 Million |
|
Lin BioScience Inc.
TWO:6696
|
$751.39 Million |
|
Northwest Healthcare Properties REIT
PINK:NWHUF
|
$751.83 Million |
|
Chambal Fertilizers & Chemicals Limited
NSE:CHAMBLFERT
|
$752.16 Million |
|
Jinzi Ham Co Ltd
SHE:002515
|
$749.68 Million |
|
Nagarro SE
PINK:NGRRF
|
$749.34 Million |
|
Jiangxi Ganyue Expressway Co Ltd
SHG:600269
|
$749.09 Million |
|
ZWSOFT Guangzhou Co Ltd
SHG:688083
|
$748.47 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Core Laboratories NV's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 251,991,000 to 279,760,000, a change of 27,769,000 (11.0%).
- Net income of 31,803,000 contributed positively to equity growth.
- Dividend payments of 1,869,000 reduced retained earnings.
- Share repurchases of 12,426,000 reduced equity.
- Other comprehensive income increased equity by 5,769,000.
- Other factors increased equity by 4,492,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $31.80 Million | +11.37% |
| Dividends Paid | $1.87 Million | -0.67% |
| Share Repurchases | $12.43 Million | -4.44% |
| Other Comprehensive Income | $5.77 Million | +2.06% |
| Other Changes | $4.49 Million | +1.61% |
| Total Change | $- | 11.02% |
Book Value vs Market Value Analysis
This analysis compares Core Laboratories NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.71x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 17.56x to 2.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.93 | $16.29 | x |
| 1996-12-31 | $1.06 | $16.29 | x |
| 1997-12-31 | $2.19 | $16.29 | x |
| 1998-12-31 | $3.26 | $16.29 | x |
| 1999-12-31 | $3.22 | $16.29 | x |
| 2000-12-31 | $3.75 | $16.29 | x |
| 2001-12-31 | $4.02 | $16.29 | x |
| 2002-12-31 | $3.89 | $16.29 | x |
| 2003-12-31 | $3.53 | $16.29 | x |
| 2004-12-31 | $3.31 | $16.29 | x |
| 2005-12-31 | $3.82 | $16.29 | x |
| 2006-12-31 | $1.34 | $16.29 | x |
| 2007-12-31 | $1.27 | $16.29 | x |
| 2008-12-31 | $3.30 | $16.29 | x |
| 2009-12-31 | $5.99 | $16.29 | x |
| 2010-12-31 | $6.00 | $16.29 | x |
| 2011-12-31 | $3.68 | $16.29 | x |
| 2012-12-31 | $3.95 | $16.29 | x |
| 2013-12-31 | $3.68 | $16.29 | x |
| 2014-12-31 | $2.11 | $16.29 | x |
| 2015-12-31 | $-0.55 | $16.29 | x |
| 2016-12-31 | $3.52 | $16.29 | x |
| 2017-12-31 | $3.36 | $16.29 | x |
| 2018-12-31 | $3.62 | $16.29 | x |
| 2019-12-31 | $3.98 | $16.29 | x |
| 2020-12-31 | $1.59 | $16.29 | x |
| 2021-12-31 | $3.35 | $16.29 | x |
| 2022-12-31 | $3.94 | $16.29 | x |
| 2023-12-31 | $4.73 | $16.29 | x |
| 2024-12-31 | $5.28 | $16.29 | x |
| 2025-12-31 | $6.02 | $16.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Core Laboratories NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.37%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.04%
- • Asset Turnover: 0.88x
- • Equity Multiplier: 2.13x
- Recent ROE (11.37%) is below the historical average (43.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 11.32% | 5.24% | 1.23x | 1.76x | $490.00K |
| 1996 | 16.24% | 7.31% | 1.32x | 1.68x | $2.96 Million |
| 1997 | 13.50% | 7.17% | 0.90x | 2.09x | $3.99 Million |
| 1998 | 10.15% | 6.99% | 0.82x | 1.77x | $300.00K |
| 1999 | 1.63% | 1.12% | 0.84x | 1.73x | $-17.49 Million |
| 2000 | 7.60% | 5.70% | 0.82x | 1.63x | $-6.03 Million |
| 2001 | 7.49% | 5.48% | 0.86x | 1.59x | $-6.93 Million |
| 2002 | -3.51% | -2.48% | 0.87x | 1.63x | $-34.88 Million |
| 2003 | 8.48% | 4.61% | 0.96x | 1.91x | $-3.34 Million |
| 2004 | 6.46% | 2.88% | 1.10x | 2.04x | $-6.74 Million |
| 2005 | 14.57% | 6.46% | 1.23x | 1.84x | $9.79 Million |
| 2006 | 115.07% | 14.36% | 1.15x | 6.98x | $75.48 Million |
| 2007 | 194.88% | 18.06% | 1.33x | 8.12x | $114.89 Million |
| 2008 | 90.80% | 18.39% | 1.45x | 3.40x | $127.79 Million |
| 2009 | 40.66% | 16.33% | 1.06x | 2.36x | $85.67 Million |
| 2010 | 50.06% | 18.24% | 1.25x | 2.20x | $115.97 Million |
| 2011 | 103.81% | 20.35% | 1.50x | 3.40x | $166.89 Million |
| 2012 | 114.98% | 22.02% | 1.54x | 3.39x | $197.28 Million |
| 2013 | 143.35% | 22.62% | 1.62x | 3.90x | $225.87 Million |
| 2014 | 273.94% | 23.73% | 1.61x | 7.19x | $248.09 Million |
| 2015 | 0.00% | 14.40% | 1.28x | 0.00x | $117.22 Million |
| 2016 | 41.14% | 10.74% | 1.04x | 3.69x | $48.37 Million |
| 2017 | 55.89% | 12.60% | 1.13x | 3.93x | $68.25 Million |
| 2018 | 49.43% | 11.35% | 1.08x | 4.03x | $63.44 Million |
| 2019 | 57.34% | 15.26% | 0.86x | 4.36x | $84.20 Million |
| 2020 | -136.53% | -20.04% | 0.86x | 7.95x | $-104.79 Million |
| 2021 | 12.61% | 4.19% | 0.81x | 3.71x | $4.08 Million |
| 2022 | 10.56% | 3.97% | 0.85x | 3.14x | $1.03 Million |
| 2023 | 16.31% | 7.19% | 0.87x | 2.61x | $14.19 Million |
| 2024 | 12.46% | 5.99% | 0.89x | 2.34x | $6.20 Million |
| 2025 | 11.37% | 6.04% | 0.88x | 2.13x | $3.83 Million |
Industry Comparison
This section compares Core Laboratories NV's net assets metrics with peer companies in the Oil & Gas Equipment & Services industry.
Industry Context
- Industry: Oil & Gas Equipment & Services
- Average net assets among peers: $5,464,315,253
- Average return on equity (ROE) among peers: -34.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Core Laboratories NV (CLB) | $279.76 Million | 11.32% | 1.13x | $750.49 Million |
| ProFrac Holding Corp. (ACDC) | $1.33 Billion | -7.35% | 1.31x | $222.04 Million |
| Atlas Energy Solutions Inc. (AESI) | $867.82 Million | 18.44% | 0.45x | $1.34 Billion |
| Akastor ASA (AKKVF) | $13.55 Billion | 9.27% | 2.55x | $54.21 Million |
| Andatee China Marine Fuel Services (AMCF) | $18.84 Million | 34.05% | 1.21x | $0.98 |
| Archrock Inc (AROC) | $2.23 Billion | -42.52% | 1.73x | $6.15 Billion |
| Anton Oilfield Services Group (ATONY) | $2.15 Billion | -9.22% | 2.02x | $381.63 Million |
| Auri Inc (AURI) | $-2.74 Million | 0.00% | 0.00x | $1.91 |
| Baker Hughes Co (BKR) | $34.50 Billion | 0.37% | 0.55x | $56.21 Billion |
| Kbridge Energy Corp (BMMCF) | $-341.75K | 0.00% | 0.00x | $880.54 |
| Bri-Chem Corp (BRYFF) | $131.44K | -348.83% | 2.61x | $4.32 Million |